Skip to main content
Arthritis Research & Therapy logoLink to Arthritis Research & Therapy
. 2024 Jul 9;26:128. doi: 10.1186/s13075-024-03357-y

Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

Javier Narvaez 1,, Elena Canadillas 2, Ivan Castellvi 3, Juan Jose Alegre 4, Vanesa Vicens‑Zygmunt 5, Guadalupe Bermudo 5, Paola Vidal-Montal 1, Maria Molina Molina 5, Joan Miquel Nolla 1
PMCID: PMC11232328  PMID: 38982531

Correction: Arthritis Res Ther 26, 122 (2024)

10.1186/s13075-024-03353-2

Following publication of the original article [1], the authors identified an error in the author name of Vanesa Vicens‑Zygmunt.

The incorrect author name is: Vanesa Vincens‑Zygmunt.

The correct author name is: Vanesa Vicens‑Zygmunt.

The author group has been updated above and the original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13075-024-03353-2.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Narváez J, Cañadillas E, Castellví I, et al. Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome. Arthritis Res Ther. 2024;26:122. doi: 10.1186/s13075-024-03353-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis Research & Therapy are provided here courtesy of BMC

RESOURCES